Clinical Use of the Interferon Inducer IIBI in Patients with Refractory Hodgkin’s Lymphoma
Author(s) -
Daniar Aspetov,
Maria Omarova,
Lyazzat Orakbay,
R K Karakulov,
Kairat Doskhozhayev,
Bayan Zhumatova,
Meruyert Chazhayeva
Publication year - 2015
Publication title -
international journal of biomedicine
Language(s) - English
Resource type - Journals
eISSN - 2158-0529
pISSN - 2158-0510
DOI - 10.21103/article5(4)_oa9
Subject(s) - refractory (planetary science) , lymphoma , inducer , medicine , chemoradiotherapy , lymph , interferon , gastroenterology , oncology , immunology , chemotherapy , pathology , biology , biochemistry , astrobiology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom